Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Schulenburg

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Transplantation|June 24, 2005
Recommendations for diagnosis of acute gastrointestinal graft-versus-host disease in the small intestineAxel Schulenburg, Peter Kalhs, Werner Rabitsch
Leukemia & Lymphoma|August 9, 2005
Brief report: practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignanciesAxel Schulenburg, Wolfgang Sperr, Werner Rabitsch, et al.
Wiener Klinische Wochenschrift|October 4, 2024
S100 as marker for immune effector cell-associated neurotoxicity syndromeAxel Schulenburg, Lina Z Rüsing, Armin Bumberger, et al.
Leukemia & Lymphoma|November 3, 2005
Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantationAxel Schulenburg, Michael Fischer, Peter Kalhs, et al.
Wiener Klinische Wochenschrift|February 28, 2016
Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantationUrsula Vogl, Gerda Leitner, Assunta Dal-Bianco, et al.
Molecular Carcinogenesis|March 13, 2014
Autocrine fibroblast growth factor 18 signaling mediates Wnt-dependent stimulation of CD44-positive human colorectal adenoma cellsInga Koneczny, Axel Schulenburg, Xenia Hudec, et al.
Transplantation and Cellular Therapy|February 26, 2022
Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading CriteriaHanna A Knaus, Theresa Rottner, Clara K Baumann, et al.
Oncology|February 25, 2025
Retrospective Analysis: S100 as Marker for Immune Effector Cell-Associated Neurotoxicity SyndromeAxel Schulenburg, Lina Rüsing, Armin Bumberger, et al.
Transplantation|July 17, 2003
Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survivalFelix Keil, Erika Prinz, Karin Moser, et al.
Journal of Hematology & Oncology|April 18, 2015
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?Axel Schulenburg, Katharina Blatt, Sabine Cerny-Reiterer, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Transplantation|June 24, 2005
Recommendations for diagnosis of acute gastrointestinal graft-versus-host disease in the small intestineAxel Schulenburg, Peter Kalhs, Werner Rabitsch
Leukemia & Lymphoma|August 9, 2005
Brief report: practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignanciesAxel Schulenburg, Wolfgang Sperr, Werner Rabitsch, et al.
Wiener Klinische Wochenschrift|October 4, 2024
S100 as marker for immune effector cell-associated neurotoxicity syndromeAxel Schulenburg, Lina Z Rüsing, Armin Bumberger, et al.
Leukemia & Lymphoma|November 3, 2005
Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantationAxel Schulenburg, Michael Fischer, Peter Kalhs, et al.
Wiener Klinische Wochenschrift|February 28, 2016
Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantationUrsula Vogl, Gerda Leitner, Assunta Dal-Bianco, et al.
Molecular Carcinogenesis|March 13, 2014
Autocrine fibroblast growth factor 18 signaling mediates Wnt-dependent stimulation of CD44-positive human colorectal adenoma cellsInga Koneczny, Axel Schulenburg, Xenia Hudec, et al.
Transplantation and Cellular Therapy|February 26, 2022
Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading CriteriaHanna A Knaus, Theresa Rottner, Clara K Baumann, et al.
Oncology|February 25, 2025
Retrospective Analysis: S100 as Marker for Immune Effector Cell-Associated Neurotoxicity SyndromeAxel Schulenburg, Lina Rüsing, Armin Bumberger, et al.
Transplantation|July 17, 2003
Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survivalFelix Keil, Erika Prinz, Karin Moser, et al.
Journal of Hematology & Oncology|April 18, 2015
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?Axel Schulenburg, Katharina Blatt, Sabine Cerny-Reiterer, et al.
Pageof 3